These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6103976)

  • 1. [Fibrinogen and fibrin degradation products in hemorrhagic fever and renal syndrome].
    Mogila TV
    Klin Med (Mosk); 1980 May; 58(5):57-60. PubMed ID: 6103976
    [No Abstract]   [Full Text] [Related]  

  • 2. [The relationship between the estimation of fibrin fibrinogen degradation products and euglobulinolytic test and its clinical significance (author's transl)].
    Xue ZM
    Zhonghua Nei Ke Za Zhi; 1981 Feb; 20(2):92-4. PubMed ID: 6118244
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kinetic alterations of coagulation-anticoagulation and the fibrinolytic system in patients with epidemic hemorrhagic fever and their significance].
    Dong CR
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):678-81, 46. PubMed ID: 2907863
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum and urinary fibrin/fibrinogen degradation products in patients with Korean hemorrhagic fever; with particular reference to disseminated intravascular coagulation and acute renal failure.
    Kim BR; Cho SH; Choi IJ; Kim DS
    Yonsei Med J; 1974; 15(2):103-14. PubMed ID: 4469703
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal disease and fibrinogen degradation products.
    Hedner U; Nilsson IM
    Adv Nephrol Necker Hosp; 1974; 3():241-71. PubMed ID: 4219704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravascular disseminated coagulation syndrome in patients with acute leukemias].
    Dmoszyńska A
    Acta Haematol Pol; 1976; 7(2):139-46. PubMed ID: 1065178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of lipid peroxidation in the pathogenesis of hemorrhagic fever with nephrotic syndrome].
    Kova'lskiĭ IuG; Piotrovich AK
    Klin Med (Mosk); 1989 Nov; 67(11):108-12. PubMed ID: 2576291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of fibrin degradation products in renal diseases in children].
    Mancini AF; Rosito P; Mei V; Tazzari R
    Minerva Pediatr; 1977 Apr; 29(15):1047-54. PubMed ID: 875983
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation.
    Hollán SR; Mód A
    Haematologia (Budap); 1976; 10(3-4):319-30. PubMed ID: 1028666
    [No Abstract]   [Full Text] [Related]  

  • 12. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)].
    Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H
    Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618
    [No Abstract]   [Full Text] [Related]  

  • 13. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FFDP (fibrin fibrinogen degradation products), D-dimers, and SFMC (soluble fibrin monomer complex)].
    Kuroso K
    Rinsho Byori; 1987 Apr; Spec No 70():224-32. PubMed ID: 3302392
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing fibrin-split products.
    Norris MK
    Nursing; 1992 Jun; 22(6):29. PubMed ID: 1614647
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disseminated intravascular coagulation in hemorrhagic fever with renal syndrome].
    Sirotin BZ; Mogila TV
    Klin Med (Mosk); 1982 Feb; 60(2):84-7. PubMed ID: 6121936
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of intravascular blood coagulation in the pathogenesis of hemorrhagic syndrome and in the clinical course of hemorrhagic fever with nephrotic syndrome].
    Bunin KV; Abdurashitov RF
    Ter Arkh; 1976; 48(7):125-31. PubMed ID: 11569
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Paracoagulation" phenomenon and fibrin- fibrinogen degradation products in acute poisoning with acetic acid].
    Kuznetsova AV
    Ter Arkh; 1977; 49(6):139-43. PubMed ID: 898038
    [No Abstract]   [Full Text] [Related]  

  • 20. [Syndrome of disseminated intravascular coagulation in the pathogenesis of vasculo-hypoxic encephalopathy in status epilepticus].
    Karlov VA; Makarov VA; Shmyrev VI; Savin AA; Rybina EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(6):828-30. PubMed ID: 7293580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.